Provision of Palliative Combined Pembrolizumab-Chemotherapy in Head and Neck Cancer in England: Time for a Review of the Evidence

被引：0
作者：
Kelly, C. [1 ]
Barnett, G. [2 ]
Iqbal, M. S. [3 ]
机构：
[1] Newcastle Tyne Hosp NHS Fdn Trust, Freeman Hosp, Northern Ctr Canc Care, Newcastle Upon Tyne NE7 7DN, England
[2] Cambridge Univ Hosp NHS Fdn Trust, Hills Rd, Cambridge CB2 0QQ, England
[3] Newcastle Univ, Freeman Hosp, Newcastle Tyne Hosp NHS Fdn Trust, Northern Ctr Canc Care, Newcastle Upon Tyne NE7 7DN, England
来源：
CLINICAL ONCOLOGY | 2024年 / 36卷 / 09期
关键词：
Chemotherapy; head and neck cancer; immunotherapy; pembrolizumab; SQUAMOUS-CELL CARCINOMA; OPEN-LABEL; CETUXIMAB; RECURRENT;
D O I：
10.1016/j.clon.2024.05.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：534 / 536
页数：3
相关论文
共 50 条
  • [31] Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer
    Spencer, S
    Wheeler, R
    Peters, G
    Meredith, R
    Beenken, S
    Nabel, L
    Wooten, A
    Soong, SJ
    Salter, M
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (02): : 118 - 122
  • [32] Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score
    Burtness, Barbara
    Rischin, Danny
    Greil, Richard
    Soulieres, Denis
    Tahara, Makoto
    de Castro Jr, Gilberto
    Psyrri, Amanda
    Brana, Irene
    Baste, Neus
    Neupane, Prakash
    Bratland, Ase
    Fuereder, Thorsten
    Hughes, Brett G. M.
    Mesia, Ricard
    Ngamphaiboon, Nuttapong
    Rordorf, Tamara
    Wan Ishak, Wan Zamaniah
    Ge, Joy
    Swaby, Ramona F.
    Gumuscu, Burak
    Harrington, Kevin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (21) : 2321 - +
  • [33] Quality of life during first-line palliative chemotherapy for recurrent and metastatic head and neck cancer with weekly cisplatin and docetaxel
    Guntinas-Lichius, Orlando
    Ruehlow, Sarah
    Veelken, Florian
    Klussmann, Jens Peter
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (07) : 901 - 908
  • [34] First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048
    Shunji Takahashi
    Nobuhiko Oridate
    Kaoru Tanaka
    Yasushi Shimizu
    Yasushi Fujimoto
    Koji Matsumoto
    Tomoya Yokota
    Tomoko Yamazaki
    Masanobu Takahashi
    Tsutomu Ueda
    Nobuhiro Hanai
    Hironori Yamaguchi
    Hiroki Hara
    Tomokazu Yoshizaki
    Ryuji Yasumatsu
    Masahiro Nakayama
    Kiyoto Shiga
    Takashi Fujii
    Kenji Mitsugi
    Kenichi Takahashi
    Nijiro Nohata
    Burak Gumuscu
    Ramona F. Swaby
    Makato Tahara
    International Journal of Clinical Oncology, 2022, 27 : 1805 - 1817
  • [35] Estimation of an optimal chemotherapy utilisation rate for head and neck carcinoma: Setting an evidence-based benchmark for the best-quality cancer care
    Ng, Weng
    Jacob, Susannah
    Delaney, Geoff
    Barton, Michael
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (12) : 2150 - 2159
  • [36] Evidence accumulating in support of cancer vaccines combined with chemotherapy: A pragmatic review of past and present efforts
    Sinkovics, Joseph G.
    Horvath, Joseph C.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 29 (04) : 765 - 777
  • [37] Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement
    Buglione, Michela
    Cavagnini, Roberta
    Di Rosario, Federico
    Maddalo, Marta
    Vassalli, Lucia
    Grisanti, Salvatore
    Salgarello, Stefano
    Orlandi, Ester
    Bossi, Paolo
    Majorana, Alessandra
    Gastaldi, Giorgio
    Berruti, Alfredo
    Trippa, Fabio
    Nicolai, Pietro
    Barasch, Andrei
    Russi, Elvio G.
    Raber-Durlacher, Judith
    Murphy, Barbara
    Magrini, Stefano M.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 102 : 47 - 54
  • [38] The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK
    Hopper, C
    Niziol, C
    Sidhu, M
    ORAL ONCOLOGY, 2004, 40 (04) : 372 - 382
  • [39] Oral mucositis in head and neck cancer: Evidence-based management and review of clinical trial data
    Blakaj, Adriana
    Bonomi, Marcelo
    Gamez, Mauricio E.
    Blakaj, Dukagjin M.
    ORAL ONCOLOGY, 2019, 95 : 29 - 34
  • [40] Applying radiobiological principles to combined modality treatment of head and neck cancer - The time factor
    Peters, LJ
    Withers, HR
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (04): : 831 - 836
12345